ion channel modulators (Neusentis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameion channel modulators (Neusentis)
Drug Alias Nameion channel modulators (ICAgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIon channels modulators
TargetsIon channels
Therapy Area/IndicationsInflammationUveitisArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeusentis Ltd
Active IndicationsN/A
Inactive IndicationsInflammationUveitisArthritis

Other Information

ATC CodeN/A
Related LinksN/A